HK1064953A1 - Compositions for nasal administration of insulin - Google Patents

Compositions for nasal administration of insulin

Info

Publication number
HK1064953A1
HK1064953A1 HK04107874A HK04107874A HK1064953A1 HK 1064953 A1 HK1064953 A1 HK 1064953A1 HK 04107874 A HK04107874 A HK 04107874A HK 04107874 A HK04107874 A HK 04107874A HK 1064953 A1 HK1064953 A1 HK 1064953A1
Authority
HK
Hong Kong
Prior art keywords
insulin
compositions
nasal administration
nasal
administration
Prior art date
Application number
HK04107874A
Other languages
English (en)
Inventor
Toshikazu Oki
Takashi Hanafusa
Shunki Haruta
Original Assignee
Translational Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Translational Res Ltd filed Critical Translational Res Ltd
Publication of HK1064953A1 publication Critical patent/HK1064953A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK04107874A 2001-07-05 2004-10-13 Compositions for nasal administration of insulin HK1064953A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001204784 2001-07-05
PCT/JP2002/006721 WO2003004048A1 (fr) 2001-07-05 2002-07-03 Compositions destinees a l'administration par voie nasale d'insuline

Publications (1)

Publication Number Publication Date
HK1064953A1 true HK1064953A1 (en) 2005-02-08

Family

ID=19041200

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04107874A HK1064953A1 (en) 2001-07-05 2004-10-13 Compositions for nasal administration of insulin

Country Status (11)

Country Link
US (2) US6906027B2 (fr)
EP (1) EP1413311A4 (fr)
JP (1) JP4721212B2 (fr)
KR (1) KR20030027108A (fr)
CN (1) CN100341567C (fr)
AU (1) AU2002346143B2 (fr)
CA (1) CA2433583A1 (fr)
HK (1) HK1064953A1 (fr)
MX (1) MXPA03005980A (fr)
RU (1) RU2299743C2 (fr)
WO (1) WO2003004048A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100341567C (zh) * 2001-07-05 2007-10-10 产业化研究株式会社 胰岛素的经鼻给药用组合物
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
JP4922762B2 (ja) * 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
JP2012526726A (ja) 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
WO2011013003A2 (fr) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Granisétron pour administration intranasale et applicateur nasal
MX2015011624A (es) 2013-03-04 2015-12-17 Besins Healthcare Lu Sarl Composiciones farmaceuticas secas que comprenden nanoparticulas de agente activo ligadas a particulas portadoras.
ES2904570T3 (es) * 2013-09-24 2022-04-05 Satsuma Pharmaceuticals Inc Formulación de DHE intranasal para el tratamiento del dolor de cabeza
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
WO2019130701A1 (fr) * 2017-12-26 2019-07-04 旭化成株式会社 Poudre de cellulose
US10758532B2 (en) 2018-12-11 2020-09-01 Satsuma Pharmaceuticals, Inc. Compositions, devices, and methods for treating or preventing headaches
US20220183971A1 (en) * 2019-05-16 2022-06-16 Shin Nippon Biomedical Laboratories, Ltd. Powder formulation for intranasal administration, and manufacturing method thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
JPS60224616A (ja) 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物
JPS6242888A (ja) 1985-08-21 1987-02-24 カシオ計算機株式会社 太陽電池を備えたｉｃカ−ド
JP2505430B2 (ja) * 1986-11-04 1996-06-12 帝人株式会社 塩基性アミノ酸を含有する経鼻投与用粉末状組成物
JPH0715963B2 (ja) 1987-08-31 1995-02-22 松下電器産業株式会社 半導体装置
JP2802488B2 (ja) * 1995-02-08 1998-09-24 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
JP3634380B2 (ja) * 1996-02-27 2005-03-30 帝人株式会社 粉末状経鼻投与組成物
JP3197221B2 (ja) 1996-02-27 2001-08-13 帝人株式会社 吸収性が改善された粉末状経鼻投与組成物
CA2341732C (fr) 1998-08-26 2008-08-19 Teijin Limited Compositions en poudre s'administrant par voie nasale
DK1025859T3 (da) 1998-08-26 2006-10-16 Teijin Ltd Pulverformige pernasale præparater
CN100341567C (zh) * 2001-07-05 2007-10-10 产业化研究株式会社 胰岛素的经鼻给药用组合物

Also Published As

Publication number Publication date
EP1413311A4 (fr) 2005-10-19
MXPA03005980A (es) 2003-09-10
US20040063615A1 (en) 2004-04-01
JP4721212B2 (ja) 2011-07-13
CN1491114A (zh) 2004-04-21
WO2003004048A1 (fr) 2003-01-16
US20050158250A1 (en) 2005-07-21
JPWO2003004048A1 (ja) 2005-11-24
EP1413311A1 (fr) 2004-04-28
AU2002346143B2 (en) 2007-10-04
CA2433583A1 (fr) 2003-01-16
RU2299743C2 (ru) 2007-05-27
RU2004103187A (ru) 2005-06-10
CN100341567C (zh) 2007-10-10
US6906027B2 (en) 2005-06-14
KR20030027108A (ko) 2003-04-03

Similar Documents

Publication Publication Date Title
IL161214A0 (en) Compositions for delivery of drug combinations
IL161446A0 (en) Medicinal compositions for nasal absorption
IL158862A0 (en) An insulin composition for pulmonary administration
EP1438086A4 (fr) Canule nasale
GB0126151D0 (en) Administration of medicaments by vaporisation
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL366874A1 (en) Nasal drug delivery devices
PL367180A1 (en) Stabilized oral pharmaceutical composition
EP1407785A4 (fr) Compositions medicinales
HK1065944A1 (en) Medicinal compositions
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
HK1064953A1 (en) Compositions for nasal administration of insulin
AU2002346143A1 (en) Compositions for nasal administration of insulin
HK1065257A1 (en) Medicinal composition
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
HUP0400115A3 (en) Pharmaceutical composition for the intramuscular administration of fulvestrant
GB0304636D0 (en) Pharmaceutical composition for nasal delivery
AU2002357935A1 (en) Dosage form for providing time-varying patterns of drug delivery
GB0228305D0 (en) Therapeutic composition for respiratory delivery
HUP0401862A3 (en) Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
GB0114746D0 (en) Medicinal composition
EP1413314A4 (fr) Composition medicinale
HUP0103049A3 (en) Use of fluexetine for preparation of pharmaceutical compositions
GB0124010D0 (en) Pharmaceutical compositions for inhalation

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120703